Effect of Sacubitril-Valsartan versus angiotensin-converting enzyme inhibitors (ACEI) and angiotensin receptor blocker (ARB) on left ventricular ejection fraction in patient with heart failure
Phase 3
Recruiting
- Conditions
- Heart failure.Heart failure
- Registration Number
- IRCT20120215009014N503
- Lead Sponsor
- Hamedan University of Medical Sciences
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Recruiting
- Sex
- All
- Target Recruitment
- 225
Inclusion Criteria
Age 18 to 80 years
Heart failure
Exclusion Criteria
Severe coronary disease
Valvular heart disease
Pulmonary thromboembolism
Congenital heart disease
Study & Design
- Study Type
- interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method
- Secondary Outcome Measures
Name Time Method
